A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1–10 Brain Metastases
Gillian Whitfield(University of Manchester), W H Wilson(Cancer Research UK), Paul Sanghera(The Edgbaston Hospital), Helen Bulbeck(Entrust), Laura Clifton‐Hadley(Cancer Research UK), D. H. Edwards(University College London), Sarah Jefferies(Addenbrooke's Hospital), Diego Megı́as(Spanish National Cancer Research Centre), Richard Shaffer(Bupa Cromwell Hospital), J. Handley(The Christie NHS Foundation Trust), Susan Short(Washburn University), Michael D. Jenkinson(University of Liverpool), Matthew Griffin(Nottingham University Hospitals NHS Trust)
Cited by 3
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Longitudinal molecular trajectories of diffuse glioma in adults
|Nature|2019|594
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532